Therapy News and Research

RSS

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

The Food and Drug Administration (FDA) has identified about 5 million doses of influenza vaccine from foreign manufacturers; HHS has been able to recoup an additional 300,000 doses of the injectable vaccine originally bought for federal employees and the military; and a major pneumonia vaccine manufacturer plans to triple its production.

29 Oct 2004

New insight into the role of the breast cancer gene known as BRCA2

Researchers at the Medical Research Council (MRC) Cancer Cell Unit, Cambridge have gained an important new insight into the role of the breast cancer gene known as BRCA2.

29 Oct 2004

Micro-array technology is revolutionising current drug development

Gene expression micro-array technology is benefiting all phases of the discovery, development and subsequent use of new cancer therapeutics

29 Oct 2004

FDA approves artificial spinal disc for use in treating pain associated with degenerative disc disease

The U.S. Food and Drug Administration (FDA) has approved an artificial spinal disc for use in treating pain associated with degenerative disc disease (DDD), a general term applied to degeneration of the lumbar spinal discs which serve as cushions between the spinal vertebrae.

28 Oct 2004

Higher radiation doses helps patients with advanced non-small cell lung cancer live longer

Treating patients with advanced non-small cell lung cancer more aggressively by giving them higher doses of radiation helps keep the disease from spreading and allows some patients to live longer

28 Oct 2004

New insights into hormone therapy show when estrogen best aids brain

New hormone therapy studies demonstrate estrogen's ability to directly stimulate neurons, repair damaged neurons, and stimulate support cells—most of which can alleviate some of the cognitive decline associated with menopause.

28 Oct 2004

Marijuana-like compounds may aid Parkinson's disease, pain and obesity

No longer a pipe dream, new animal research now indicates that marijuana-like compounds can aid a bevy of debilitating conditions, ranging from brain disorders such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease, to pain and obesity.

28 Oct 2004

Brief psychological interventions are effective in relieving traumatic stress symptoms in family members

Family therapy and other psychological treatments may help reduce symptoms of post-traumatic stress among teenaged survivors of childhood cancer--as well as among their parents.

28 Oct 2004

Gastric acid-suppressive medications may increase risk of developing pneumonia

Individuals who use gastric acid-suppressive medications may be at an elevated risk of developing community-acquired pneumonia, according to an article in the October 27 issue of JAMA.

28 Oct 2004

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Human Genome Sciences today announced an agreement with GlaxoSmithKline under which GlaxoSmithKline has acquired exclusive worldwide rights to develop and commercialize Albugon (albumin-glucagon-like peptide-1, GLP-1), a drug currently in late-stage preclinical development by Human Genome Sciences for potential use in the treatment of diabetes.

26 Oct 2004

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Eli Lilly and Company's investigational compound ruboxistaurin may reduce vision loss from diabetes-induced eye disease, according to new analyses of previously reported data presented at the 2004 Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology in New Orleans, La.

26 Oct 2004

Magnetic resonance guidance may improve the long-term success of treatment for deforming birthmark

Magnetic resonance (MR) guidance may improve the long-term success of treatment for low-flow vascular malformations, according to a study published in the November issue of the journal Radiology.

26 Oct 2004

Researchers investigate new treatment options, including ways to boost immune responses to better control HIV

Highly active antiretroviral therapy (HAART) for the treatment of individuals infected by HIV-1 is limited by high costs, drug resistance, and drug-related toxicities. This has led researchers to investigate new treatment options, including ways to boost immune responses to better control HIV.

25 Oct 2004

New oral vaccine treatment is effective in reducing Alzheimer's disease pathology

Alzheimer's disease is characterized by progressive loss of cognitive function due to amyloid-beta (Aß) deposits in the central nervous system. If these deposits could be stopped or slowed, Alzheimer's disease might become more manageable.

25 Oct 2004

Treating childhood sexual abuse

Women with a history of childhood sexual abuse take many years to report what happened – but derive benefit from one-on-one therapy as adults.

25 Oct 2004

Can traditional Chinese medicine relieve symptoms of menopause

A woman experiencing the odd hot flush when glimpsing Brad Pitt decked out in his 'Troy' gear might be normal, but uncontrolled flushing because of menopause usually isn't so welcome.

25 Oct 2004

New help to explain treatments for colorectal cancer

To help patients and their families better understand how different treatments work to cure colorectal cancer, the American Society for Therapeutic Radiology and Oncology has published the new patient information brochure Radiation Therapy for Colorectal Cancer: Facts to Help People Understand Their Treatment Options.

25 Oct 2004

National Cancer Institute symposium exploring the application of nanotechnology in the diagnosis, treatment and prevention of cancer

The Case Comprehensive Cancer Center, which includes The Cleveland Clinic Taussig Cancer Center and the Ireland Cancer Center at University Hospitals of Cleveland, will sponsor a National Cancer Institute symposium exploring the application of nanotechnology in the diagnosis, treatment and prevention of cancer.

25 Oct 2004

Men undergoing prostate cancer therapy forget things faster

Oregon Health & Science University researchers studying how testosterone deprivation affects verbal memory found that men undergoing the prostate cancer therapy forget things faster than their healthy counterparts.

25 Oct 2004

Boehringer Ingelheim - New Drug Application (NDA) for tipranavir

The Company is seeking accelerated approval of tipranavir and has requested a priority, six-month review of the NDA. Priority review designation is based upon whether a drug provides a significant improvement in the treatment of a serious or life-threatening disease.

25 Oct 2004

Therapy News and Research

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

New insight into the role of the breast cancer gene known as BRCA2

Micro-array technology is revolutionising current drug development

FDA approves artificial spinal disc for use in treating pain associated with degenerative disc disease

Higher radiation doses helps patients with advanced non-small cell lung cancer live longer

New insights into hormone therapy show when estrogen best aids brain

Marijuana-like compounds may aid Parkinson's disease, pain and obesity

Brief psychological interventions are effective in relieving traumatic stress symptoms in family members

Gastric acid-suppressive medications may increase risk of developing pneumonia

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Magnetic resonance guidance may improve the long-term success of treatment for deforming birthmark

Researchers investigate new treatment options, including ways to boost immune responses to better control HIV

New oral vaccine treatment is effective in reducing Alzheimer's disease pathology

Treating childhood sexual abuse

Can traditional Chinese medicine relieve symptoms of menopause

New help to explain treatments for colorectal cancer

National Cancer Institute symposium exploring the application of nanotechnology in the diagnosis, treatment and prevention of cancer

Men undergoing prostate cancer therapy forget things faster

Boehringer Ingelheim - New Drug Application (NDA) for tipranavir

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News